| abstract |
The invention concerns the use of 2-amino-4-pyridylmethyl-thiazoline derivatives of formula (I), wherein: either R1 = R2 = Cl, or C1-C4 alkyl, or hydroxy; or C1-C4 alkoxy or at least one of the two R1 and R2 is hydrogen and the other a C1-C4 alkyl radical, a hydroxy, a C1-C4 alkoxy or a chlorine or their pharmaceutically acceptable salts as inhibitors of inducible NO-synthase. |